FDA Inspection 1052408 — Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) on Apr 17, 2018 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)